[Skip to Navigation]
Comment & Response
February 6, 2019

Mohs Appropriate Use Criteria for Superficial Basal Cell Carcinoma

Author Affiliations
  • 1Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
  • 2Florida Center for Dermatology, P.A., St Augustine, Florida
JAMA Dermatol. 2019;155(3):395. doi:10.1001/jamadermatol.2018.4572

To the Editor I read with great interest the Viewpoint by Steinman and colleagues1 on treating superficial basal cell carcinoma (sBCC) with Mohs surgery. The authors rightly point to the paucity of evidence regarding sBCC management, though this limitation applies not just to sBCC but to most other nonmelanoma skin cancers as well.2

Add or change institution